You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

21-386

Showing 1 - 25 of 5,023
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Completed
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +15 more
  • trebananib
  • +3 more
  • Buffalo, New York
  • +1 more
Sep 8, 2022

Hypertension and Dyslipidemia Trial in Seoul (CKD-386(4) F1, CKD-386(4) F2, D013, D326, D337)

Completed
  • Hypertension and Dyslipidemia
  • CKD-386(4) F1
  • +2 more
  • Seoul, Korea, Republic of
    H+ Yangji Hospita
Jan 10, 2023

COVID-19 Trial in San Juan (Educational intervention)

Recruiting
  • COVID-19
  • Educational intervention
  • San Juan, Puerto Rico
  • +1 more
Jul 19, 2022

Lymphoma Trial in New York (N-Acetylcysteine)

Recruiting
  • Lymphoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Aug 24, 2022

COVID-19 Trial in Worldwide (SARS-CoV-2 adjuvanted recombinant protein vaccine (monovalent), SARS-CoV-2 adjuvanted recombinant

Active, not recruiting
  • COVID-19
  • SARS-CoV-2 adjuvanted recombinant protein vaccine (monovalent)
  • +2 more
  • Birmingham, Alabama
  • +93 more
Jul 22, 2022

Hypertension and Dyslipidemia Trial in Seoul (CKD-386(5), D013, D326, D337)

Not yet recruiting
  • Hypertension and Dyslipidemia
  • Seoul, Korea, Republic of
    H plus Yangji hospital
Jan 16, 2023

Ultrasound Scanning for Fetal Growth

Recruiting
  • Stillbirth
  • +6 more
    • Oxford, Oxfordshire, United Kingdom
      Oxford University Hospitals NHS Foundation Trust
    Nov 2, 2022

    Motion Sickness Trial in Santa Monica (DPI-386 Nasal Gel, Placebo)

    Recruiting
    • Motion Sickness
    • DPI-386 Nasal Gel
    • Placebo
    • Santa Monica, California
      Santa Monica Clinical Trials
    Sep 16, 2022

    Prostatic Tumors, Castration-Resistant Trial in Worldwide (Atezolizumab, Enzalutamide)

    Active, not recruiting
    Has Results
    • Prostatic Neoplasms, Castration-Resistant
    • Duarte, California
    • +157 more
    Oct 26, 2022

    Chart Review of Repatha® in Subjects With Hyperlipidaemia

    Completed
    • Hypercholesterolaemia
      • Feldkirch, Austria
      • +183 more
      Jul 15, 2022

      SARS-CoV-2 Infection, COVID-19 Trial in United Kingdom (SARS-CoV-2 rS/Matrix M1-Adjuvant, Placebo, Licensed seasonal influenza

      Active, not recruiting
      • SARS-CoV-2 Infection
      • COVID-19
      • SARS-CoV-2 rS/Matrix M1-Adjuvant
      • +2 more
      • Belfast, Antrim, United Kingdom
      • +32 more
      Oct 19, 2022

      Cerebral Vascular Accident Trial in Schenectady (High Intensity Gait Training, Conventional Therapy)

      Not yet recruiting
      • Cerebral Vascular Accident
      • High Intensity Gait Training
      • Conventional Therapy
      • Schenectady, New York
        Sunnyview Rehabilitation Hospital
      Dec 6, 2022

      Hypertension and Dyslipidemia Trial (CKD-386(3), D013, D326, D337)

      Not yet recruiting
      • Hypertension and Dyslipidemia
      • (no location specified)
      Feb 16, 2022

      SARS-CoV 2 Trial in Montréal, Québec (Intramuscular Vaccine)

      Completed
      • SARS-CoV 2
      • Intramuscular Vaccine
      • Montréal, Quebec, Canada
      • +1 more
      Apr 4, 2022

      COVID-19, Cancer, Nicotine Dependence Trial in Madison

      Completed
      • COVID-19
      • +5 more
        • Madison, Wisconsin
          University of Wisconsin School of Medicine and Public Health Cen
        Aug 17, 2022

        Sentinel Lymph Node Biopsy in Initially Lymph Node-positive,

        Completed
        • Breast Cancer
        • Sentinel Lymph Node
        • Test cohort
        • Fuzhou, Fujian, China
          Chuan Wang
        Nov 25, 2023

        Hypertension and Dyslipidemia Trial in Seoul (CKD-386(2), D013, D326, D337)

        Completed
        • Hypertension and Dyslipidemia
        • Seoul, Korea, Republic of
          H plus Yangji hospital
        Jan 20, 2022

        Bile Duct Adenocarcinoma Trial in Hangzhou (surufatinib plus cadonilimab)

        Recruiting
        • Bile Duct Adenocarcinoma
        • surufatinib plus cadonilimab
        • Hangzhou, Zhejiang, China
          Zhejiang Cancer Hospital
        Oct 15, 2023

        SARS-CoV-2 Infection Trial in Osaka-shi, Suita-shi, Shinjuku-ku (MT-2766 High dose, Placebo, MT-2766 Low dose)

        Active, not recruiting
        • SARS-CoV-2 Infection
        • MT-2766 High dose
        • +2 more
        • Osaka-shi, Osaka, Japan
        • +2 more
        Mar 25, 2022

        Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer

        Recruiting
        • Lung Cancer
          • Shanghai, China
            Shanghai Chest Hospital
          Jul 20, 2023

          SARS-CoV-2 Infection Trial in Worldwide (Intramuscular injection, Intramuscular vaccine)

          Active, not recruiting
          • SARS-CoV-2 Infection
          • Intramuscular injection
          • Intramuscular vaccine
          • Birmingham, Alabama
          • +90 more
          Apr 4, 2022

          Contraceptive, Sexually Transmitted Diseases Trial in Berkeley, Los Angeles (Test Product, Control Product)

          Recruiting
          • Contraceptive
          • Sexually Transmitted Diseases
          • Test Product
          • Control Product
          • Berkeley, California
          • +1 more
          Aug 10, 2022

          Migraine Trial in Japan (Placebo, Erenumab)

          Completed
          Has Results
          • Migraine
          • Kamogawa-shi, Chiba, Japan
          • +43 more
          Oct 3, 2022

          Insomnia Trial in Hong Kong (Dexmedetomidine, Zolpidem, Placebo)

          Recruiting
          • Insomnia
          • Hong Kong, Guangdong, China
            HKU Li Ka Shing Faculty of Medicine
          Nov 7, 2022

          Ocular Redness Trial in United States (Brimonidine tartrate ophthalmic solution 0.025% preservative-free formulation, Lumify®

          Recruiting
          • Ocular Redness
          • Brimonidine tartrate ophthalmic solution 0.025% preservative-free formulation
          • Lumify® (brimonidine tartrate ophthalmic solution 0.025%)
          • Colorado Springs, Colorado
          • +5 more
          Oct 3, 2022